Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (371-380 of 529) with videos related to

Pageof 53
Sort By:
Molecular Cancer Therapeutics|April 3, 2019
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast CancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Scientific Reports|June 16, 2015
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerBenjamin D Ferguson, Yi-Hung Carol Tan, Rajani S Kanteti, et al.
Journal of Clinical Medicine|October 23, 2019
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer CellsTamara Mirzapoiazova, Haiqing Li, Anusha Nathan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2020
Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitorsDan Zhao, Isa Mambetsariev, Haiqing Li, et al.
Journal of Clinical Medicine|June 18, 2020
Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care SitesCary A Presant, Ravi Salgia, Prakash Kulkarni, et al.
Molecular Cancer Therapeutics|December 16, 2014
A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumorsKari L Kendra, Ruth Plummer, Ravi Salgia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Frontiers in Oncology|March 22, 2021
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung CancerBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Molecular Cancer Therapeutics|March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Cancer Research|August 20, 2014
AXL mediates resistance to cetuximab therapyToni M Brand, Mari Iida, Andrew P Stein, et al.
Pageof 53

Showing results (371-380 of 529) with videos related to

Sort By:
Pageof 53
Molecular Cancer Therapeutics|April 3, 2019
Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast CancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Scientific Reports|June 16, 2015
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerBenjamin D Ferguson, Yi-Hung Carol Tan, Rajani S Kanteti, et al.
Journal of Clinical Medicine|October 23, 2019
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer CellsTamara Mirzapoiazova, Haiqing Li, Anusha Nathan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2020
Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitorsDan Zhao, Isa Mambetsariev, Haiqing Li, et al.
Journal of Clinical Medicine|June 18, 2020
Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care SitesCary A Presant, Ravi Salgia, Prakash Kulkarni, et al.
Molecular Cancer Therapeutics|December 16, 2014
A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumorsKari L Kendra, Ruth Plummer, Ravi Salgia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Frontiers in Oncology|March 22, 2021
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung CancerBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Molecular Cancer Therapeutics|March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Cancer Research|August 20, 2014
AXL mediates resistance to cetuximab therapyToni M Brand, Mari Iida, Andrew P Stein, et al.
Pageof 53